Adebrelimab Plus S-1 for Resected Cholangiocarcinoma

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
Adebrelimab Plus S-1 for Resected Cholangiocarcinoma	Biliary Tract Neoplasms, Digestive System Diseases, Digestive System Neoplasms, Neoplasms by Histologic Type, Neoplasms by Site, adenocarcinoma, biliary tract cancer, biliary tract disorder, carcinoma, cholangiocarcinoma, epithelial neoplasm, neoplasm	Not yet recruiting	Phase 2	2026-05-01		NCT07561775

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
Xingjun Guo	1

0 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
No products are listed yet.

Clinical trials